Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0

Posted on By

Analytical Method Development: Residual Solvent Estimation by HPLC – V 2.0

SOP for Estimation of Residual Solvents Using HPLC in Pharmaceutical Products


Department Analytical Method Development
SOP No. SOP/AMD/080/2025
Supersedes SOP/AMD/080/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the procedure for developing and executing a High-Performance Liquid Chromatography (HPLC) method for estimation of residual solvents in active pharmaceutical ingredients (APIs)

and finished pharmaceutical products, particularly where gas chromatography (GC) is unsuitable due to volatility or matrix interferences.

2. Scope

This procedure applies to the Analytical Method Development (AMD) laboratory and is used to quantify Class 2 and Class 3 solvents (e.g., isopropyl alcohol, ethanol, acetone) in samples using a validated HPLC approach, in alignment with ICH Q3C limits and GMP guidelines.

3. Responsibilities

  • Analytical Chemist: Develops and validates the HPLC method, prepares standard and sample solutions, and ensures proper documentation.
  • Method Reviewer: Ensures accuracy and regulatory compliance of the developed method.
  • QA Officer: Verifies GMP-compliant documentation and cross-verifies validation output.
  • Head – AMD: Reviews and approves method for use in quality control or regulatory submission.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring residual solvent methods meet ICH and pharmacopoeial standards for detection and quantification.

See also  Analytical Method Development: SOP for TGA Method for Moisture and Volatile Content - V 2.0

5. Procedure

5.1 Selection of Residual Solvents

  1. Identify residual solvents from manufacturing or formulation history.
  2. Refer to ICH Q3C (R8) for classification and limits:
    • Class 2 (e.g., methanol, acetone): 3000–5000 ppm
    • Class 3 (e.g., ethanol, IPA): 5000 ppm
  3. Document selected solvents in Annexure-1: Residual Solvent Selection Sheet.

5.2 Chromatographic Condition Selection

  1. Column: C18, 250 mm × 4.6 mm, 5 µm.
  2. Mobile Phase:
    • Water:methanol or Water:acetonitrile in 70:30 or 60:40 ratio.
    • Additives (e.g., 0.1% phosphoric acid) to improve separation.
  3. Detection: UV at 210–220 nm depending on solvent absorbance.
  4. Flow Rate: 1.0 mL/min; Injection Volume: 50 µL (larger than typical assay injections).
  5. Record settings in Annexure-2: HPLC Conditions Log.

5.3 Standard and Sample Preparation

  1. Standard Preparation:
    • Prepare individual and mixed standard stock solutions of solvents in water or diluent.
    • Dilute to concentrations near ICH limits (e.g., 2000–5000 ppm).
  2. Sample Preparation:
    • Weigh API or formulation (e.g., 500 mg) into 10 mL volumetric flask.
    • Extract with diluent using sonication, then dilute and filter.
  3. Document all weights and dilutions in Annexure-3: Sample & Standard Preparation Log.

5.4 Specificity and Linearity

  1. Inject blank, standard, and sample to verify no interference at solvent RTs.
  2. Prepare linearity curve for each solvent (50%, 75%, 100%, 125%, 150%).
  3. Acceptance criteria: R² ≥ 0.995.
  4. Document results in Annexure-4: Linearity and Specificity Report.
See also  Analytical Method Development: SOP for Development of pH Method for Injections - V 2.0

5.5 Accuracy and Precision

  1. Accuracy:
    • Spike blank matrix (API without solvents) at 80%, 100%, and 120% levels.
    • Recovery range: 95–105%
  2. Precision:
    • Repeat injection of standard solution (n=6); %RSD ≤ 5%
  3. Document in Annexure-5: Accuracy and Precision Log.

5.6 Limit of Detection (LOD) and Limit of Quantification (LOQ)

  1. Determine LOD and LOQ based on signal-to-noise (S/N) method:
    • LOD: S/N ≥ 3
    • LOQ: S/N ≥ 10
  2. Confirm %RSD at LOQ is ≤10%.
  3. Record in Annexure-6: LOD/LOQ Summary.

5.7 Robustness and System Suitability

  1. Change flow rate ±0.1 mL/min, pH ±0.2, or detection wavelength ±2 nm.
  2. Evaluate impact on retention time and resolution.
  3. System Suitability Criteria:
    • RSD of solvent peak areas ≤ 5%
    • Resolution between solvents ≥ 2.0
  4. Document in Annexure-7: Robustness and Suitability Report.

6. Abbreviations

  • HPLC: High-Performance Liquid Chromatography
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • ICH: International Council for Harmonisation
  • RSD: Relative Standard Deviation
  • SOP: Standard Operating Procedure

7. Documents

  1. Residual Solvent Selection Sheet – Annexure-1
  2. HPLC Conditions Log – Annexure-2
  3. Sample & Standard Preparation Log – Annexure-3
  4. Linearity and Specificity Report – Annexure-4
  5. Accuracy and Precision Log – Annexure-5
  6. LOD/LOQ Summary – Annexure-6
  7. Robustness and Suitability Report – Annexure-7
See also  Analytical Method Development: SOP for Residual Solvent Detection in Granules - V 2.0

8. References

  • ICH Q3C(R8) – Impurities: Guideline for Residual Solvents
  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <467> – Residual Solvents
  • USP <621> – Chromatography

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Residual Solvent Selection Sheet

Solvent Class ICH Limit (ppm) Included in Method
Isopropyl Alcohol Class 3 5000 Yes

Annexure-2: HPLC Conditions Log

Column Mobile Phase Flow Rate Wavelength Run Time
C18, 250×4.6 mm Water:Methanol (70:30) 1.0 mL/min 210 nm 15 min

Annexure-3: Sample & Standard Preparation Log

ID Type Concentration Diluent Prepared By
STD-001 IPA Standard 4000 ppm Water Rajesh Kumar

Annexure-4: Linearity and Specificity Report

Level Concentration (ppm) Area R²
100% 4000 265432 0.9996

Annexure-5: Accuracy and Precision Log

Level Recovery (%) RSD (%) Status
100% 99.2 1.4 Pass

Annexure-6: LOD/LOQ Summary

Solvent LOD (ppm) LOQ (ppm) S/N @ LOQ
IPA 80 260 11

Annexure-7: Robustness and Suitability Report

Parameter Variation Observation Status
Flow Rate ±0.1 mL/min RT shift < 0.5 min Acceptable

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added larger injection volume guidance and LOD/LOQ criteria Annual SOP Update
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Handling Overages in Batch Preparation – V 2.0
Next Post: API Manufacturing: SOP for Preparation of Volumetric Solutions – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version